Express News | S&P downgraded ModivCare's outlook to negative, confirming its long-term debt rating.
Cracking The Code: Understanding Analyst Reviews For ModivCare
Barrington Maintains ModivCare(MODV.US) With Buy Rating, Cuts Target Price to $19
Barrington analyst Michael Petusky maintains $ModivCare(MODV.US)$ with a buy rating, and adjusts the target price from $35 to $19.According to TipRanks data, the analyst has a success rate of 50.3%
Lake Street Maintains ModivCare(MODV.US) With Buy Rating, Cuts Target Price to $30
Lake Street analyst Brooks O'Neil maintains $ModivCare(MODV.US)$ with a buy rating, and adjusts the target price from $50 to $30.According to TipRanks data, the analyst has a success rate of 45.4%
Outlook Positive: ModivCare's Strategic Financial Recovery and Growth Prospects
Barrington Research Adjusts ModivCare Price Target to $19 From $35, Maintains Outperform Rating